FDA staff endorsed Johnson & Johnson's (JNJ) COVID-19 vaccine for emergency use
- Futures dip after S&P 500, Dow hit record closing highs
- UK to Intervene on National Security Grounds on NVIDIA (NVDA) and Arm Deal
- GameStop (GME) announces George Sherman will be stepping down as CEO
- Dollar slumps to 6-week low, Bitcoin steadies after weekend drop
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
FDA staff endorsed Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine for emergency use
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Analysis: Countries seek more Moderna, Pfizer/BioNTech COVID-19 shots as concerns mount over rival vaccines
- Anixa Biosciences (ANIX) and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy
- Astellas and Seagen (SGEN) Announce U.S. FDA Acceptance of Two SBLAs for PADCEV in Locally Advanced or Metastatic Urothelial Cancer